España
Italia
대한민국
日本
Français
My Account
Benzinga Edge
Benzinga Research
Benzinga Pro
Login
Get Benzinga Pro
Data & APIs
Events
Premarket
Advertise
Contribute
España
Italia
대한민국
日本
Français
Login
Register
Premium Services
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Financial News
Latest
Earnings
Guidance
Dividends
M&A
Buybacks
Interviews
Management
Offerings
IPOs
Insider Trades
Biotech/FDA
Politics
Healthcare
Small-Cap
Markets
Pre-Market
After Hours
Movers
ETFs
Options
Cryptocurrency
Commodities
Bonds
Futures
Mining
Real Estate
Volatility
Ratings
Analyst Color
Downgrades
Upgrades
Initiations
Price Target
Investing Ideas
Trade Ideas
Long Ideas
Short Ideas
Technicals
Analyst Ratings
Analyst Color
Latest Rumors
Whisper Index
Stock of the Day
Best Stocks & ETFs
Best Penny Stocks
Best S&P 500 ETFs
Best Swing Trade Stocks
Best Blue Chip Stocks
Best High-Volume Penny Stocks
Best Small Cap ETFs
Best Stocks to Day Trade
Best REITs
Money
Investing
Cryptocurrency
Mortgage
Insurance
Yield
Personal Finance
Forex
Startup Investing
Real Estate Investing
Prop Trading
Credit Cards
Stock Brokers
Research
My Stocks
Tools
Free Benzinga Pro Trial
Calendars
Analyst Ratings Calendar
Conference Call Calendar
Dividend Calendar
Earnings Calendar
Economic Calendar
FDA Calendar
Guidance Calendar
IPO Calendar
M&A Calendar
Unusual Options Activity Calendar
SPAC Calendar
Stock Split Calendar
Trade Ideas
Free Stock Reports
Insider Trades
Trade Idea Feed
Analyst Ratings
Unusual Options Activity
Heatmaps
Free Newsletter
Government Trades
Perfect Stock Portfolio
Easy Income Portfolio
Short Interest
Most Shorted
Largest Increase
Largest Decrease
Calculators
Margin Calculator
Forex Profit Calculator
100x Options Profit Calculator
Screeners
Stock Screener
Top Momentum Stocks
Top Quality Stocks
Top Value Stocks
Top Growth Stocks
Compare Best Stocks
Best Momentum Stocks
Best Quality Stocks
Best Value Stocks
Best Growth Stocks
Recent
Markets
Reiteration
Apple Services Revenue Trajectory Signals Softness With Weaker App Store Downloads: Analyst
Oracle's Exceptional Backlog Confirms Its Role As Key AI Enabler: Analyst
Opendoor's New CEO Could Spark 'Bigger Pivot'—Analyst Sees Bottom-Line Boost
Oracle's Exceptional Backlog Confirms Its Role As Key AI Enabler: Analyst
Opendoor's New CEO Could Spark 'Bigger Pivot'—Analyst Sees Bottom-Line Boost
Robinhood Stock A Buy With Short Selling, Social Trading Coming: Analyst Says Company Is Maturing
Coursera Leverages AI To Drive Upskilling Boom, But Analyst Isn't Fully Convinced
Robinhood Stock A Buy With Short Selling, Social Trading Coming: Analyst Says Company Is Maturing
Coursera Leverages AI To Drive Upskilling Boom, But Analyst Isn't Fully Convinced
Apple's iPhone 17 Impresses On Design, But Analysts Say AI Still Lags
Robinhood Fills 'Glaring Product Gap'—Analyst Calls It A Game-Changer
Read More...
Reiteration Recent News
Synopsys Analysts Flag Restructuring Needs, China Headwinds After Q3 Miss
Synopsys Inc (SNPS) stock tanks on downbeat Q3 results. BofA analyst downgrades to Underperform, Needham maintains Buy. SNPS shares down 34.90%.
Netflix's High Labor Productivity Is A 'Strong Positive' For Shareholders,' Says Bullish Analyst
Labor productivity, a leading indicator for share prices, has remained high at Netflix from 2021 to 2025, Laura Martin says.
Johnson & Johnson Kicks Off 'Powerful New Product Cycle': Analyst
Johnson & Johnson analyst Asad Haider says Inlexzo is currently the only intravesical iDRS to deliver cancer meds directly into the bladder.
Dan Ives Says Apple iPhone 17 Marks 'New Era,' Sets Up Super Cycle After AI Strategy Held Shares Back
Apple analyst Dan Ives breaks down the highlights from the company's iPhone 17 event and predicts what comes next.
Casey's Stock Slips As Strong Q1 Results Overshadowed By 'Disappointing' 2026 Guidance
Despite strong earnings, Casey's General Stores stock drops. Analyst maintains Overweight rating and $530 price target. Shares down 1.55%.
Dell Technologies Strategy Remains Steady Despite CFO Departure, Say Analysts
Dell Tech (DELL) CFO Yvonne McGill departs Sept 9, 2025 before SAM. David Kennedy (COO Global Sales) named interim CFO as JPMorgan maintains Overweight rating.
Planet Labs Beats Estimates, But Analysts Warn On Growth And Margins
Planet Labs' stock falls despite strong Q2 results, as analysts raise target prices. Revenue and EBITDA beat consensus, with positive cash flow.
Duolingo Set To Unveil Major Product Updates At Duocon 2025
Duolingo to unveil updates at Duocon conference on September 16, including video call features, Energy System expansion, and non-language offerings.
Oracle Q2 Preview: Analyst Highlights 'AI-Related Bookings Momentum' With Shares Near All-Time Highs
Oracle looks to highlight cloud and AI-related growth when the company reports Q1 results Tuesday, Sept. 9.
Palantir's Value-Based Business Approach Is Macro Insulated, Says Analyst
Palantir Technologies (PLTR) is a top AI player, helping customers gain real-world benefits. Analyst maintains Buy rating with price forecast of $180.
Roblox Analysts Cheer Developer Payout Hike, See Path To Stronger Growth
Analysts are optimistic about Roblox Corp after its Developers Conference, with BofA Securities maintaining a Buy rating and JPMorgan reaffirming Overweight.
Chewy Set For Growth As Analysts Highlight Market Share And Strong Execution
Chewy is forecast to beat Q2 sales guidance with projected revenue of $3.08 billion as analysts highlight its strong position in the online pet market.
Lululemon Plunges As Analysts Downgrade Stock On Weaker Sales Outlook
Lululemon (LULU) stock drops after mixed Q2 results and lowered guidance. Analysts downgrade ratings and price targets due to sales miss and tariff pressures.
Create a Watchlist
FREE: Follow your stocks and cryptocurrencies with the most actionable alerts on the internet.
Click to Get Started